NCT00737854

Brief Summary

Oral lichen planus is a common chronic mucocutaneous disease with various clinical forms. Erosive-ulcerative forms usually cause symptoms of pain and discomfort. The most important complication of OLP is development of oral squamous cell carcinoma, although this is a very controversial matter. various treatments have been suggested for OLP but their results are unsatisfactory. Through the experiences of the investigators, corticosteroids (in any form)is not a wise option for treating OLP and has many side effects . More over, immunosuppressive therapy did not influence the risk for oral cancer. The purpose of the study is to determine the efficacy of free soft tissue graft in the treatment of precancerous and symptomatic lesions of OLP. Removal of the lesions up to submucosa has been done. The graft sliced from healthy mucosa also up to submucosa. Then graft will be sutured in position. According to other authors, basal epithelial layers of the graft remain intact and represent the focus of re-epithelization. New epithelial cells migrate over the basal membrane and appear to guide it by proliferation, will generate new epithelium. The wound is re-epithelialized by proliferation of surrounding healthy epithelial cell, therefore, not contaminated by modified antigens of the cell membrane that are theoretically responsible for lymphocyte aggression. The healthy graft remains free of lesions and appears clinically healthy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started May 2008

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 18, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 20, 2008

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

December 11, 2008

Status Verified

August 1, 2008

Enrollment Period

2 years

First QC Date

August 18, 2008

Last Update Submit

December 9, 2008

Conditions

Keywords

OLPFree Soft Tissue GraftTreatment

Outcome Measures

Primary Outcomes (1)

  • Relief of sign & symptoms (every 2 month up to 1 years)

    1 year

Secondary Outcomes (1)

  • Relief of sign & symptoms and no positive histopathologic features of OLP

    (time frame 1 years)

Study Arms (1)

1 ARM

EXPERIMENTAL

Otherwise healthy patients with oral lichen planus (precancerous/erosive OLP)

Procedure: Surgical resection

Interventions

20 patients with OLP will be selected for this study. Before this routine treatment modalities had been attempted. Removal of possible triggering drug was also considered. Local ethical committee approval will be obtained before the trial starts. Surgical procedure includes: removal of the tissue up to submucosa (containing antigenic properties that caused OLP). A specimen will be sent for histopathologic analysis. The graft sliced from healthy mucosa also up to submucosa. Then the graft trimmed on a gauze soaked in saline and adapted to recipient site. The graft was sutured in position. Checking will be done after 1 week and every two months up to 1 year. Punch biopsy will be done in 1 year after surgery for histopathologic investigations.

Also known as: surgical resection of OLP
1 ARM

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Biopsy confirmed symptomatic oral lichen planus: WHO histological criteria in combination with clinical appearance will be used for diagnosis
  • Previous routine treatment modalities has been attempted including steroids and immunomodulatory or antioxidant agents. i.e patients who had resistant lesions to routine treatment .removal of possible triggering drugs was also considered.
  • Patients of both sexes between 40 to 70 year's old
  • Patients who have symptoms such as burning sensation, pain
  • Patients who have localized precancerous lesions such as atrophic-erosive/plaque like lichen planus with diameter lesser than 2 cm
  • Patients who agree to this treatment
  • Patients who are willing for evaluation in first week after surgery and every two month for 1 years
  • Patients who agree to final punch biopsy for histopathologic evaluation

You may not qualify if:

  • Patients who unable to undergo oral surgery
  • Patients suffering from any localized or systemic disease
  • Pregnant patients
  • Smokers
  • Patients who can not continue the study for private or social reasons
  • Patients with generalized oral lichen planus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Qazvin University of Medical Sciences

Qazvin, Qazvin State, 3415759811, Iran

RECRUITING

MeSH Terms

Conditions

Lichen Planus, Oral

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesLichen PlanusLichenoid EruptionsSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Farshid Rayati, DDS

    Qazvin University Of Medical Sciences

    STUDY DIRECTOR
  • Tuba(Aida) Karagah, DDS

    QUMS

    PRINCIPAL INVESTIGATOR
  • Farshid Rayati, DDS

    QUMS

    STUDY CHAIR
  • Saeid Asefzadeh, PHD

    QUMS

    STUDY CHAIR
  • Poopak masumi, DDS-MS

    QUMS

    STUDY DIRECTOR
  • pourya falah, student

    QUMS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Farshid - Rayati, DDS

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 18, 2008

First Posted

August 20, 2008

Study Start

May 1, 2008

Primary Completion

May 1, 2010

Study Completion

December 1, 2010

Last Updated

December 11, 2008

Record last verified: 2008-08

Locations